FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2890739906> ?p ?o ?g. }

• W2890739906 endingPage "255" @default.
• W2890739906 startingPage "247" @default.
• W2890739906 abstract "The RNA oxidation product, 8-oxo-7,8-dihydroguanosine (8-oxoGuo), has been associated with mortality in patients with type 2 diabetes (T2D). However, the identification and the potential effect of approved treatments decreasing urine 8-oxoGuo level remain unraveled. In the Steno-2 study intensified multifactorial treatment compared with conventional multifactorial treatment reduced mortality in T2D patients with microalbuminuria by 45%. We assessed association between 8-oxoGuo at advanced baseline and total mortality with up to 19.9 years follow-up and from end of intervention to end of follow-up up to (up to 13.9 years). In 1993, 160 T2D patients with microalbuminuria were included in the Steno-2 trial. Urine samples from baseline were not available, but samples were available from 155 patients (97%) in 1995 (advanced baseline) and from 125 patients (96%) in 2001 (end of intervention). Hazard ratios (HR) for log2-transformed 8-oxoGuo and dichotomized (cut-off at median; low vs. high RNA oxidation) were estimated using Cox regressions. During follow-up of 19.9 years after advanced baseline, 89 died and no association between 8-oxoGuo and mortality was found (p = 0.40). From the end of 7.8 years of intervention and during remaining 13.9 years of observation, 61 died and doubling the urine 8-oxoGuo level was associated with mortality with a HR 3.08 (95% CI [1.86 −5.12]; p < 0.001) after multiple adjustments. Patients with low 8-oxoGuo in the intensified-treatment had the lowest risk of dying compared with high 8-oxoGuo in the conventional-treatment both from advanced baseline onwards, adjusted HR 0.40 (95% CI [0.21 −0.75]; p = 0.004), and from end of intervention onwards, adjusted HR 0.28 (95% CI [0.13 −0.61]; p = 0.001). In T2D patients with microalbuminuria, high levels of urine 8-oxoGuo after 7.8 years of multifactorial intervention was associated with higher mortality during 13.9 years of post-trial follow-up. Patients with low 8-oxoGuo in the intensified treatment group had the lowest risk of dying." @default.
• W2890739906 created "2018-09-27" @default.
• W2890739906 creator A5021458180 @default.
• W2890739906 creator A5021753819 @default.
• W2890739906 creator A5042890915 @default.
• W2890739906 creator A5066665434 @default.
• W2890739906 creator A5072411696 @default.
• W2890739906 creator A5075178587 @default.
• W2890739906 date "2018-12-01" @default.
• W2890739906 modified "2023-09-24" @default.
• W2890739906 title "Indicator of RNA oxidation in urine for the prediction of mortality in patients with type 2 diabetes and microalbuminuria: A post-hoc analysis of the Steno-2 trial" @default.
• W2890739906 cites W1983937216 @default.
• W2890739906 cites W1998171008 @default.
• W2890739906 cites W2005715757 @default.
• W2890739906 cites W2008788704 @default.
• W2890739906 cites W2023559965 @default.
• W2890739906 cites W2026480246 @default.
• W2890739906 cites W2054382152 @default.
• W2890739906 cites W2067422515 @default.
• W2890739906 cites W2071850731 @default.
• W2890739906 cites W2083990676 @default.
• W2890739906 cites W2087533214 @default.
• W2890739906 cites W2105731956 @default.
• W2890739906 cites W2105927085 @default.
• W2890739906 cites W2124098523 @default.
• W2890739906 cites W2134293572 @default.
• W2890739906 cites W2138040710 @default.
• W2890739906 cites W2165201727 @default.
• W2890739906 cites W2170271198 @default.
• W2890739906 cites W2170591272 @default.
• W2890739906 cites W2412299019 @default.
• W2890739906 cites W2513040800 @default.
• W2890739906 cites W2606281213 @default.
• W2890739906 cites W2765283031 @default.
• W2890739906 cites W2779223875 @default.
• W2890739906 cites W2780477037 @default.
• W2890739906 cites W2790501791 @default.
• W2890739906 cites W4248078302 @default.
• W2890739906 doi "https://doi.org/10.1016/j.freeradbiomed.2018.09.030" @default.
• W2890739906 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30244028" @default.
• W2890739906 hasPublicationYear "2018" @default.
• W2890739906 type Work @default.
• W2890739906 sameAs 2890739906 @default.
• W2890739906 citedByCount "10" @default.
• W2890739906 countsByYear W28907399062019 @default.
• W2890739906 countsByYear W28907399062020 @default.
• W2890739906 countsByYear W28907399062021 @default.
• W2890739906 countsByYear W28907399062022 @default.
• W2890739906 crossrefType "journal-article" @default.
• W2890739906 hasAuthorship W2890739906A5021458180 @default.
• W2890739906 hasAuthorship W2890739906A5021753819 @default.
• W2890739906 hasAuthorship W2890739906A5042890915 @default.
• W2890739906 hasAuthorship W2890739906A5066665434 @default.
• W2890739906 hasAuthorship W2890739906A5072411696 @default.
• W2890739906 hasAuthorship W2890739906A5075178587 @default.
• W2890739906 hasBestOaLocation W28907399061 @default.
• W2890739906 hasConcept C126322002 @default.
• W2890739906 hasConcept C134018914 @default.
• W2890739906 hasConcept C159641895 @default.
• W2890739906 hasConcept C168563851 @default.
• W2890739906 hasConcept C207103383 @default.
• W2890739906 hasConcept C2777180221 @default.
• W2890739906 hasConcept C2780026642 @default.
• W2890739906 hasConcept C2781203188 @default.
• W2890739906 hasConcept C44249647 @default.
• W2890739906 hasConcept C50382708 @default.
• W2890739906 hasConcept C555293320 @default.
• W2890739906 hasConcept C67761136 @default.
• W2890739906 hasConcept C71924100 @default.
• W2890739906 hasConceptScore W2890739906C126322002 @default.
• W2890739906 hasConceptScore W2890739906C134018914 @default.
• W2890739906 hasConceptScore W2890739906C159641895 @default.
• W2890739906 hasConceptScore W2890739906C168563851 @default.
• W2890739906 hasConceptScore W2890739906C207103383 @default.
• W2890739906 hasConceptScore W2890739906C2777180221 @default.
• W2890739906 hasConceptScore W2890739906C2780026642 @default.
• W2890739906 hasConceptScore W2890739906C2781203188 @default.
• W2890739906 hasConceptScore W2890739906C44249647 @default.
• W2890739906 hasConceptScore W2890739906C50382708 @default.
• W2890739906 hasConceptScore W2890739906C555293320 @default.
• W2890739906 hasConceptScore W2890739906C67761136 @default.
• W2890739906 hasConceptScore W2890739906C71924100 @default.
• W2890739906 hasFunder F4320311377 @default.
• W2890739906 hasFunder F4320322436 @default.
• W2890739906 hasLocation W28907399061 @default.
• W2890739906 hasLocation W28907399062 @default.
• W2890739906 hasLocation W28907399063 @default.
• W2890739906 hasOpenAccess W2890739906 @default.
• W2890739906 hasPrimaryLocation W28907399061 @default.
• W2890739906 hasRelatedWork W1995659049 @default.
• W2890739906 hasRelatedWork W2100182767 @default.
• W2890739906 hasRelatedWork W2100928316 @default.
• W2890739906 hasRelatedWork W2126483958 @default.
• W2890739906 hasRelatedWork W2128693594 @default.
• W2890739906 hasRelatedWork W2164255543 @default.
• W2890739906 hasRelatedWork W2572837865 @default.
• W2890739906 hasRelatedWork W3108721673 @default.
• W2890739906 hasRelatedWork W4353083550 @default.

• next